GNH USA

Europe — EMA

Natriumchlorid-Einmolar Fresenius (Sodium Chloride)

GNH USA supplies Natriumchlorid-Einmolar Fresenius (Sodium Chloride), an electrolyte for fluid replacement, electrolyte replenishment and hyponatremia.

Request sourcing

1
Pack/s

What is Sodium Chloride?

Sodium Chloride, the active ingredient in Natriumchlorid-Einmolar Fresenius, is an electrolyte presented as a 1 M solution for injection for intravenous use. It restores sodium and chloride balance and expands extracellular fluid volume in patients requiring fluid and electrolyte replacement.

GNH USA supplies Natriumchlorid-Einmolar Fresenius as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Sodium Chloride used for?

Natriumchlorid‑Einmolar Fresenius is used in clinical situations that involve fluid loss or electrolyte imbalance.

- Fluid replacement: restores intravascular volume in patients with dehydration or blood loss. - Electrolyte replenishment: corrects sodium and chloride deficits after surgery, trauma, or diuretic therapy. - Hypovolemia: supports circulatory volume to maintain blood pressure and organ perfusion. - Hyponatremia: raises serum sodium concentration in patients with low sodium levels.

What are the side effects of Sodium Chloride?

Sodium chloride injection is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Hypernatremia: elevated serum sodium levels. - Hyperchloremia: increased serum chloride concentration. - Infusion site irritation or phlebitis. - Fluid overload: signs of edema or pulmonary congestion. - Electrolyte imbalance: transient shifts in other electrolytes.

Serious or Rare Side Effects: - Severe hypernatremia leading to neurological symptoms. - Pulmonary edema with respiratory distress. - Anaphylactic or severe allergic reaction. - Cardiac arrhythmias due to rapid electrolyte changes. - Metabolic acidosis from chloride load. - Severe hypotension from rapid infusion.

What precautions apply to Sodium Chloride?

Before using Natriumchlorid‑Einmolar Fresenius, clinicians should consider several safety measures.

- Assess fluid status: evaluate volume status and signs of dehydration. - Monitor electrolytes: check serum Na⁺ and Cl⁻ regularly during therapy. - Adjust infusion rate: tailor the speed to patient tolerance and clinical response. - Use caution in renal impairment: risk of fluid overload and electrolyte accumulation. - Contraindicated in hypernatremia: avoid if serum sodium >150 mEq/L. - Store at ambient temperature: keep in original container, protect from light and moisture.

What does Sodium Chloride interact with?

Sodium chloride solution can interact with other medications that affect fluid and electrolyte balance.

Major Interactions (Avoid): - Concurrent hypertonic saline: may cause severe hypernatremia. - Loop diuretics: can exacerbate electrolyte shifts and volume depletion. - ACE inhibitors or ARBs: increased risk of hyperkalemia when combined with high chloride load.

Moderate Interactions (Monitor Closely): - Corticosteroids: may augment fluid retention. - NSAIDs: can impair renal function, increasing risk of fluid overload. - Anticoagulants: rapid volume expansion may affect hemodynamics and bleeding risk.

Frequently asked questions

What is Natriumchlorid‑Einmolar Fresenius used for?+
Natriumchlorid‑Einmolar Fresenius is an intravenous 1 M sodium chloride solution used to replace lost fluids and electrolytes, treat hypovolemia, correct hyponatremia, and support patients who need rapid expansion of extracellular fluid volume.
How does sodium chloride work in the body?+
The solution provides sodium and chloride ions that increase extracellular osmolarity, drawing water into the vascular space. This expands plasma volume, restores electrolyte balance, and helps maintain normal cellular and acid‑base functions.
What is the usual dose of Natriumchlorid‑Einmolar Fresenius?+
The prescribed dose is determined by the treating clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. Dosing is individualized and should follow the prescriber’s instructions.
Is Natriumchlorid‑Einmolar Fresenius safe during pregnancy or breastfeeding?+
Safety data for use in pregnancy and lactation are limited. The product should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under medical supervision.
How do I order Natriumchlorid‑Einmolar Fresenius from GNH USA?+
Enquiries are submitted via the product page on gnh-usa.com, where you specify the required quantity. GNH USA supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.
How does Natriumchlorid‑Einmolar compare with other electrolyte solutions?+
Compared with lower‑concentration saline (0.9 % NaCl), the 1 M formulation delivers a higher sodium load per milliliter, allowing faster correction of severe hyponatremia or rapid volume expansion. Choice depends on the clinical need, patient tolerance and physician judgment.
What are the storage and handling requirements for this product?+
Store the solution at ambient temperature, below 25 °C, in its original sealed container. Protect from direct sunlight, moisture and extreme temperatures to maintain sterility and solution integrity.
How is Natriumchlorid‑Einmolar administered?+
The product is given intravenously. It is typically infused through a peripheral or central line, with the rate adjusted according to the patient’s hemodynamic status and electrolyte targets, as directed by the prescriber.
What are the most serious risks associated with this medication?+
Serious risks include severe hypernatremia, pulmonary edema, anaphylactic reactions, and cardiac arrhythmias due to rapid electrolyte shifts. Monitoring of serum electrolytes and fluid status is essential to mitigate these risks.
Who should not receive Natriumchlorid‑Einmolar Fresenius?+
Patients with existing severe hypernatremia, uncontrolled heart failure, or those who are unable to tolerate rapid fluid expansion should not receive this product unless closely monitored by a qualified healthcare professional.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Sodium Chloride
Route
Intravenous Use
Manufacturer
Fresenius Kabi Deutschland Gmbh
Origin
EU

Related products